The RCMI program provides universally accessible equipment, infrastructure and analysis essential to initiate and sustain research projects at Meharry. In this application, we will address continuity of services and efficiency of resource management by bringing all the supported core equipment and functions into one continuous space, which will be renovated. Therefore, we are also requesting funds to renovate this space. We will accomplish this goal through the following specific aims: 1) Co-localize and merge three independent cores (Molecular Biology, Morphology, Proteomics), and an animal imaging instrument into the research infrastructure core 2) Expand research services and analysis by continuing to support bioinformatics activity, adding health informatics, and increasing biostatistics support 3) Centrally manage the research infrastructure core facility (CRISALIS) to ensure appropriate tracking, billing, and grant attribution by users 4) Cross-train seven staff scientists and junior faculty broadly to provide continuous and uninterrupted service 5) Renovate 5,000 sq. ft. of space to accommodate the specialized scientific instruments and personnel. By accomplishing these specific aims, we will centralize operations, increase efficiencies and create a more robust infrastructure for research services and training. This enhanced, unified strategic direction and execution will allow for uniformity, prioritizing future directions, and increased productivity by reducing redundancies in previously separate operations. The transformation of the space and cores into a more efficient and highly integrated research services suite will lower the startup cost burden of the newly recruited faculty while also providing excellent service value for our existing researchers.!

National Institute of Health (NIH)
National Institute on Minority Health and Health Disparities (NIMHD)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZMD1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Meharry Medical College
United States
Zip Code
Xie, Yingqiu; Fan, Haiyan; Lu, Wenfu et al. (2018) Nuclear MET requires ARF and is inhibited by carbon nanodots through binding to phospho-tyrosine in prostate cancer. Oncogene :
Archibong, Anthony E; Rideout, Meredith L; Harris, Kenneth J et al. (2018) OXIDATIVE STRESS IN REPRODUCTIVE TOXICOLOGY. Curr Opin Toxicol 7:95-101
Smith Jr, Joseph T; Singha, Ujjal K; Misra, Smita et al. (2018) Divergent Small Tim Homologues Are Associated with TbTim17 and Critical for the Biogenesis of TbTim17 Protein Complexes in Trypanosoma brucei. mSphere 3:
McIntosh, Deneshia J; Walters, Treniqka S; Arinze, Ifeanyi J et al. (2018) Arkadia (RING Finger Protein 111) Mediates Sumoylation-Dependent Stabilization of Nrf2 Through K48-Linked Ubiquitination. Cell Physiol Biochem 46:418-430
Choi, Wonyoung; Kim, Jeongsik; Park, Jaeoh et al. (2018) YAP/TAZ Initiates Gastric Tumorigenesis via Upregulation of MYC. Cancer Res 78:3306-3320
Mimura, Kousaku; Teh, Jun Liang; Okayama, Hirokazu et al. (2018) PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer. Cancer Sci 109:43-53
Ochieng, Josiah; Nangami, Gladys; Sakwe, Amos et al. (2018) Extracellular histones are the ligands for the uptake of exosomes and hydroxyapatite-nanoparticles by tumor cells via syndecan-4. FEBS Lett 592:3274-3285
Mishra, Abheepsa; Ayasolla, Kamesh; Kumar, Vinod et al. (2018) Modulation of apolipoprotein L1-microRNA-193a axis prevents podocyte dedifferentiation in high-glucose milieu. Am J Physiol Renal Physiol 314:F832-F843
Abney, Kristopher K; Ramos-Hunter, Susan J; Romaine, Ian M et al. (2018) Selective Activation of N,N'-Diacyl Rhodamine Pro-fluorophores Paired with Releasing Enzyme, Porcine Liver Esterase (PLE). Chemistry 24:8985-8988
Ho, Meng-Hsuan; Lamont, Richard J; Chazin, Walter J et al. (2018) Characterization and development of SAPP as a specific peptidic inhibitor that targets Porphyromonas gingivalis. Mol Oral Microbiol 33:430-439

Showing the most recent 10 out of 57 publications